Sully Omar: Cognosys, Automating Workflows With AI, Reactions To Claude3 Dethroning GPT4, and more!| SVIC Podcast

By Jordan

In This Article:
    Add a header to begin generating the table of contents

    Secure your financial future with our free newsletter!

    Thank you for subscribing to the Silicon Valley Investors Club’s Newsletter – Investors Therapy!

    You will receive updates directly in your inbox.


    Patreon.com/svic

    Sully discusses the creation and development of Cognosys, an AI platform that automates workflows using natural language processing, including the challenges faced and solutions implemented. They explore open problems in AI development, such as billing and termination issues. The conversation delves into the evolution of AI models, the future of retrieval augmentation generation (RAG) and large context models, and topics like simplifying AI systems, agentic models, and surprising use cases.

    Show hosts Joe (Eng VP) and Jordan (M&A Deal Lead) worked at various companies from Google, Apple, Facebook, Microsoft, Salesforce, Slack, Carta, Splunk, Wealthfront, Adobe, Microsoft, and more.

    🤩Here the rest of the interview & get access to new stories and blog posts for the episode and the ones we didn’t have time to cover, our book recommendations, exclusive episodes and latest AI research for only $5 at patreon.com/svic

    Takeaways
    00:00 Introduction and Background
    01:35 How Cognosys.ai went virtal
    05:30 How AutoGen Evolved Into Cognosys
    12:17 Picking The Right LLMs
    18:00 Big Challenges Cognosys Is Trying To Solve
    20:43 How GPT-5 Can Make Your AI Technique Obsolete
    31:20 Determine Product Pricing
    33:45 Customer Surprises And Product Roadmap
    37:45 GPT-4 Dethroned By Claude 3
    42:45 Using Claude 3 to write code

    #openai #claude #ai #artificialintelligence #chatgpt #gpt4

    You May Also Like:

    Join our free newsletter for the latest SVIC blog posts and special commentary only for our newsletter subscribers.

    Join Investors Therapy Today!

    [blog_newsletter_subs_form]

    Join our free newsletter for the latest SVIC blog posts and special commentary only for our newsletter subscribers.

    Join Investors Therapy Today!

    [blog_newsletter_subs_form]

    You are being redirected to a third party site.

    We are redirecting you to one of our third party partners.